Preventive maintenance and repair service agreement for a biorad QX200 ddpcr system
Ended Awarded Last action
- Contract number
- 75F40122F80304
- Awardee
-
The Remi Group LLC UEI X458FNVQ1YX9
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $13,190
Award facts
- Contract value 100% obligated
- $13,189.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a delivery order valued at $13.19K to The Remi Group LLC for preventive maintenance and repair services on a Bio-Rad QX200 ddPCR system at the FDA's Silver Spring, Maryland facility. This firm fixed-price delivery order, issued on August 16, 2022, with completion targeted for September 19, 2023, represents a child order issued under The Remi Group's existing Indefinite Delivery/Indefinite Quantity Blanket Purchase Agreement with the Centers for Disease Control and Prevention. The Remi Group, a Charlotte, North Carolina-based equipment maintenance specialist, is well-established in federal contracting with SAM.gov registration since 2008 and extensive experience supporting scientific and medical instrumentation across civilian and defense agencies.
The delivery order supports the FDA's laboratory operations through comprehensive equipment maintenance services for sophisticated analytical instrumentation. The Remi Group's service portfolio includes preventive maintenance, emergency repairs, replacement parts, software updates, and technical support for diverse laboratory equipment. The contractor operates under two significant IDVs—a $10M Veterans Affairs BPA and a $49.56B CDC BPA through the General Services Administration Multiple Award Schedule—positioning the company to deliver responsive maintenance support across federal scientific research and healthcare infrastructure. No set-aside designation was applied to this delivery order.
Quick answers
Who was awarded contract 75F40122F80304?
75F40122F80304 was awarded to The Remi Group LLC by Food and Drug Administration (Department of Health and Human Services) on August 16, 2022.
How much is contract 75F40122F80304 worth?
The government has obligated $13,190 on 75F40122F80304.
Is contract 75F40122F80304 an order under another contract?
Yes. 75F40122F80304 is a delivery order under GS21F0093V, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 75F40122F80304 competed?
The extent of competition for 75F40122F80304 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award